Invention Grant
- Patent Title: Herpes simplex virus nanoemulsion vaccine
-
Application No.: US13591775Application Date: 2012-08-22
-
Publication No.: US10206996B2Publication Date: 2019-02-19
- Inventor: Ali I. Fattom , Jakub Simon , James R. Baker, Jr. , Tarek Hamouda , Vira Bitko
- Applicant: Ali I. Fattom , Jakub Simon , James R. Baker, Jr. , Tarek Hamouda , Vira Bitko
- Applicant Address: US MI Ann Arbor
- Assignee: NanoBio Corporation
- Current Assignee: NanoBio Corporation
- Current Assignee Address: US MI Ann Arbor
- Agency: Foley & Lardner LLP
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/245 ; A61K39/39 ; A61K9/107 ; A61K39/12
Abstract:
The present application relates to the field of human immunology, in particular, a herpes simplex virus (HSV) vaccine. The subunit vaccine composition comprises isolated surface glycoproteins from herpes simplex viruses, fusion proteins or fragments thereof mixed in varied combination with a nanoemulsion, which is a potent immune enhancer.
Public/Granted literature
- US20130052235A1 HERPES SIMPLEX VIRUS NANOEMULSION VACCINE Public/Granted day:2013-02-28
Information query
